Equity - Schedule of Warrants Activity (Details) - Warrant [Member] - $ / shares |
12 Months Ended | |
|---|---|---|
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Schedule of Warrants Activity [Line Items] | ||
| Number of warrants, Outstanding at beginning of the year | 202,251 | 202,251 |
| Weighted average exercise price, Outstanding at beginning of the year | $ 23.31 | $ 23.31 |
| Number of warrants, Issued | 8,954,287 | |
| Weighted average exercise price, Issued | $ 1.19 | |
| Number of warrants, Exercised | (1,511,429) | |
| Weighted average exercise price, Exercised | $ 0.001 | |
| Number of warrants, Outstanding and exercisable at year-end | 7,645,109 | 202,251 |
| Weighted average exercise price, Outstanding and exercisable at year-end | $ 2.007 | $ 23.31 |
| X | ||||||||||
- Definition The weighted average fair value at exercised for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|